Full Title: Creating and Restoring Equal Access to Equivalent Samples Act of 2019.
Summary: To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. Cosponsors
ANGIE CRAIG’S POSITION: Representative Craig cosponsored the bill on 3/27/19.
- “The CREATES Act, a bill that I am proud to cosponsor, just passed out of committee yesterday. This critical common-sense solution to rising drug costs would allow more affordable generic drugs to enter the market and lower healthcare costs for families.” (Source: Twitter, 1/05/19)
STATUS: Introduced 2/5/19 by Rep. Cicilline, David N. [D-RI-1].
ORGANIZATIONS IN SUPPORT OF THE BILL:
- “On behalf of our activist community, I urge you to contact your representative and senators and ask them to support the CREATES Act, H.R. 965 and S. 340. Introduced in the House by Reps. David Cicilline (D-R.I.) and Jim Sensenbrenner (R-Wisc.) and in the Senate by Sens. Patrick Leahy (D-Vt.), Chuck Grassley (R-Iowa), Mike Lee (R-Utah), and Amy Klobuchar (D-Minn.), the CREATES Act would lower prescription drug prices by giving competitors greater standing to sue pharmaceutical companies for predatory, monopolistic practices.” (Source: Adam Brandon, President, FeedomWorks)
- “Nearly 50 health care and consumer groups, including the AHA, voiced their support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act as it was reintroduced yesterday in the new Congress.” (Source: American Hospital Association)